NR
GILD icon

Newfound Research’s Gilead Sciences GILD Stock Holding History

Newfound Research’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$88K Buy
1,429
+40
+3% +$2.52K 0.22% 24
2022
Q2 		$86K Buy
1,389
+288
+26% +$17.8K 0.18% 66
2022
Q1 		$65K Buy
+1,101
New +$70.4K 0.08% 133
2020
Q2 		– Sell
-16
Closed -$1K – 101
2020
Q1 		$1K Hold
16
– – ﹤0.01% 62
2019
Q4 		$1K Sell
16
-6
-27% -$391 ﹤0.01% 110
2019
Q3 		$1K Hold
22
– – ﹤0.01% 121
2019
Q2 		$1K Buy
22
+4
+22% +$263 ﹤0.01% 119
2019
Q1 		$1K Hold
18
– – ﹤0.01% 118
2018
Q4 		$1K Buy
18
+2
+13% +$140 ﹤0.01% 102
2018
Q3 		$1K Buy
16
+1
+7% +$76 ﹤0.01% 142
2018
Q2 		$1K Buy
15
+1
+7% +$71 ﹤0.01% 130
2018
Q1 		$1K Buy
+14
New +$1.11K ﹤0.01% 127

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Newfound Research's GILD Position: Q3 2022 in Review

Newfound Research increased its Gilead Sciences (GILD) stake by 2.9% in Q3 2022, buying an estimated $2.52K and bringing the position to 1,429 shares worth $88K. The position accounts for 0.22% of the portfolio, ranked #24.

Newfound Research first reported a position in GILD in Q1 2018 and has held it in 12 quarters since. 1,603 funds tracked by Wall St. Rank hold GILD as of Q3 2022.

  • Newfound Research held 1,429 shares of Gilead Sciences worth $88K as of Q3 2022.
  • Newfound Research bought 40 Gilead Sciences shares in Q3 2022, an estimated $2.52K.
  • Gilead Sciences made up 0.22% of Newfound Research's portfolio in Q3 2022, its #24 holding.
  • Newfound Research first reported a position in Gilead Sciences in Q1 2018 and has held it in 12 quarters since.
  • 1,603 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.

Based on Newfound Research's 13F filing for Q3 2022, filed 13 Oct 2022.